Market Intelligence Ecosystem
Krishna Institute of Medical Sciences Ltd. (NSE: KIMS) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Rahul Jeewani -- IIFL Institutional Equities
https://youtu.be/XGfFd6kLFCE Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY22 Earnings Concall Management Update: LALPATHLAB said it saw significant shift towards
Dr Lal PathLabs Ltd (NSE: LALPATHLAB) Q4 FY22 Earnings Concall dated May. 17, 2022 Corporate Participants: Nishid Solanki -- Arvind Lal -- Executive Chairman Om
Alkem Laboratories Ltd. (NSE: ALKEM) Q4 FY22 Earnings Concall dated May. 13, 2022 Corporate Participants: Gagan Borana -- Investor Relations Sandeep Singh -- Managing Director Rajesh
Aarti Drugs Ltd. (NSE: AARTIDRUGS) Q4 FY22 Earnings Concall dated May. 10, 2022 Corporate Participants: Adhish Patil -- Chief Financial Officer Ankush Mahajan -- Axis Securities
https://youtu.be/au71QUL41tY Key highlights from Glenmark Life Sciences Limited (GLS) Q4 FY22 Earnings Concall Q&A Highlights: Neha Manpuria of Bank of America asked
Apollo Hospitals(NSE:APOLLOHOSP) reported its third-quarter 2022 earnings results. The hospital chain had a consolidated revenue of ₹3,656 crores with a growth of
https://youtu.be/vd7Dp7Vceio Key highlights from Max Healthcare Institute Ltd (MAXHEALTH) Q3 FY22 Earnings Concall Management Update: MAXHELATH achieved the highest ever operating EBITDA
https://www.youtube.com/watch?v=ECd3N-qiOMo Key highlights from Prevest Denpro Limited (PREVEST) Q3 FY22 Earnings Concall Q&A Highlights: Pranay Jain from Dealwell Capital asked that since
https://youtu.be/bwoNY3Y0LHo Key highlights from Cupid Limited (CUPID) Q3 FY22 Earnings Concall Management Update: CUPID stated that the top and bottom line performance
https://www.youtube.com/watch?v=Mzpw87FqOBE Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q3 FY22 Earnings Concall Management Update: GLENMARK stated the India business continues to outperform
https://www.youtube.com/watch?v=iqM668J91yY Key highlights from Sequent Scientific Limited (SEQUENT) Q3 FY22 Earnings Concall Management Update: SEQUENT saw significant improvement in the API order
https://www.youtube.com/watch?v=q_lILVipT-E Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY22 Earnings Concall Management Update: The company is enhancing access of its
Aurobindo Pharma Limited (NSE :AUROPHARMA) Q3 2022 Earnings Concall Feb. 10, 2022, Corporate Participants: Arvind Bothra -- Investor Relations Department Santhanam Subramanian
The estimated size of the hospital market in India was ₹4,270 billion in the fiscal year 2020, representing an annual growth of
https://www.youtube.com/watch?v=VEV5IjVrTNI Key highlights from Jubilant Ingrevia Ltd (JUBLINGREA) Q3 FY22 Earnings Concall Management Update: JUBLINGREA commented that with its capex plans shaping
Marico Ltd (NSE:MARICO) Q3 FY22 Earnings Concall dated Jan. 28, 2022 Corporate Participants: Saugata Gupta -- Managing Director & Chief Executive Officer Pawan
The pharma giant Cipla's net profit rose 7.57% year-on-year (YoY) to Rs 712 crore for Q2 FY22. Cipla market research report covers
SBI LIFE INSURANCE CO LTD (NSE:SBILIFE) Q3 FY22 Earnings Concall dated Jan. 21, 2022 Corporate Participants: Mahesh Kumar Sharma -- Managing Director and
Healthcare spending in India grew at a healthy compound annual rate of 13% from 2015 to 2019 and reached around ₹9.6 trillion.
The Indian pharmaceutical industry is the world’s third-largest by volume and 14th largest by value. The turnover of the country’s pharmaceutical market